Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group.
Identifieur interne : 006A04 ( PubMed/Corpus ); précédent : 006A03; suivant : 006A05Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group.
Auteurs : M V Pilepich ; S O Asbell ; G S Mulholland ; T. PajakSource :
- The Prostate [ 0270-4137 ] ; 1984.
English descriptors
- KwdEn :
- Biopsy, Carcinoma (pathology), Carcinoma (radiotherapy), Carcinoma (surgery), Follow-Up Studies, Humans, Lymph Node Excision, Lymph Nodes (pathology), Lymphatic Metastasis, Lymphedema (epidemiology), Male, Neoplasm Staging, Prostatic Neoplasms (pathology), Prostatic Neoplasms (radiotherapy), Prostatic Neoplasms (surgery), Radiotherapy Dosage, Random Allocation.
- MESH :
- epidemiology : Lymphedema.
- pathology : Carcinoma, Lymph Nodes, Prostatic Neoplasms.
- radiotherapy : Carcinoma, Prostatic Neoplasms.
- surgery : Carcinoma, Prostatic Neoplasms.
- Biopsy, Follow-Up Studies, Humans, Lymph Node Excision, Lymphatic Metastasis, Male, Neoplasm Staging, Radiotherapy Dosage, Random Allocation.
Abstract
One hundred thirty-six patients with carcinoma of the prostate entered on phase III RTOG studies (RTOG 75-06 and RTOG 77-06) between 1976 and the end of 1980 underwent staging lymphadenectomy prior to irradiation. The operative reports and histological findings have been reviewed in order to determine the patterns of intrapelvic tumor spread and to correlate the type of surgical procedure and the extent of lymphatic dissection with the incidence and type of postirradiation complications (primarily genital and lower extremity lymphedema). The surgical procedures were classified into three categories according to extent: 1) biopsy only, 2) limited (diagnostic) dissection, and 3) complete (therapeutic) dissection. The incidence of postirradiation lymphedema was found to be strongly dependent upon the extent of dissection. Patients undergoing limited (diagnostic) dissection followed by pelvic irradiation have a 25-30% risk of developing this debilitating complication. In patients undergoing complete (therapeutic) dissection followed by pelvic irradiation lymphedema has been observed in 66% of cases.
PubMed: 6483687
Links to Exploration step
pubmed:6483687Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group.</title><author><name sortKey="Pilepich, M V" sort="Pilepich, M V" uniqKey="Pilepich M" first="M V" last="Pilepich">M V Pilepich</name></author><author><name sortKey="Asbell, S O" sort="Asbell, S O" uniqKey="Asbell S" first="S O" last="Asbell">S O Asbell</name></author><author><name sortKey="Mulholland, G S" sort="Mulholland, G S" uniqKey="Mulholland G" first="G S" last="Mulholland">G S Mulholland</name></author><author><name sortKey="Pajak, T" sort="Pajak, T" uniqKey="Pajak T" first="T" last="Pajak">T. Pajak</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1984">1984</date><idno type="RBID">pubmed:6483687</idno><idno type="pmid">6483687</idno><idno type="wicri:Area/PubMed/Corpus">006A04</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">006A04</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group.</title><author><name sortKey="Pilepich, M V" sort="Pilepich, M V" uniqKey="Pilepich M" first="M V" last="Pilepich">M V Pilepich</name></author><author><name sortKey="Asbell, S O" sort="Asbell, S O" uniqKey="Asbell S" first="S O" last="Asbell">S O Asbell</name></author><author><name sortKey="Mulholland, G S" sort="Mulholland, G S" uniqKey="Mulholland G" first="G S" last="Mulholland">G S Mulholland</name></author><author><name sortKey="Pajak, T" sort="Pajak, T" uniqKey="Pajak T" first="T" last="Pajak">T. Pajak</name></author></analytic><series><title level="j">The Prostate</title><idno type="ISSN">0270-4137</idno><imprint><date when="1984" type="published">1984</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biopsy</term><term>Carcinoma (pathology)</term><term>Carcinoma (radiotherapy)</term><term>Carcinoma (surgery)</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymph Nodes (pathology)</term><term>Lymphatic Metastasis</term><term>Lymphedema (epidemiology)</term><term>Male</term><term>Neoplasm Staging</term><term>Prostatic Neoplasms (pathology)</term><term>Prostatic Neoplasms (radiotherapy)</term><term>Prostatic Neoplasms (surgery)</term><term>Radiotherapy Dosage</term><term>Random Allocation</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Carcinoma</term><term>Lymph Nodes</term><term>Prostatic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Carcinoma</term><term>Prostatic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Carcinoma</term><term>Prostatic Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Biopsy</term><term>Follow-Up Studies</term><term>Humans</term><term>Lymph Node Excision</term><term>Lymphatic Metastasis</term><term>Male</term><term>Neoplasm Staging</term><term>Radiotherapy Dosage</term><term>Random Allocation</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">One hundred thirty-six patients with carcinoma of the prostate entered on phase III RTOG studies (RTOG 75-06 and RTOG 77-06) between 1976 and the end of 1980 underwent staging lymphadenectomy prior to irradiation. The operative reports and histological findings have been reviewed in order to determine the patterns of intrapelvic tumor spread and to correlate the type of surgical procedure and the extent of lymphatic dissection with the incidence and type of postirradiation complications (primarily genital and lower extremity lymphedema). The surgical procedures were classified into three categories according to extent: 1) biopsy only, 2) limited (diagnostic) dissection, and 3) complete (therapeutic) dissection. The incidence of postirradiation lymphedema was found to be strongly dependent upon the extent of dissection. Patients undergoing limited (diagnostic) dissection followed by pelvic irradiation have a 25-30% risk of developing this debilitating complication. In patients undergoing complete (therapeutic) dissection followed by pelvic irradiation lymphedema has been observed in 66% of cases.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">6483687</PMID><DateCreated><Year>1984</Year><Month>11</Month><Day>01</Day></DateCreated><DateCompleted><Year>1984</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2004</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0270-4137</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>5</Issue><PubDate><Year>1984</Year></PubDate></JournalIssue><Title>The Prostate</Title><ISOAbbreviation>Prostate</ISOAbbreviation></Journal><ArticleTitle>Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group.</ArticleTitle><Pagination><MedlinePgn>471-6</MedlinePgn></Pagination><Abstract><AbstractText>One hundred thirty-six patients with carcinoma of the prostate entered on phase III RTOG studies (RTOG 75-06 and RTOG 77-06) between 1976 and the end of 1980 underwent staging lymphadenectomy prior to irradiation. The operative reports and histological findings have been reviewed in order to determine the patterns of intrapelvic tumor spread and to correlate the type of surgical procedure and the extent of lymphatic dissection with the incidence and type of postirradiation complications (primarily genital and lower extremity lymphedema). The surgical procedures were classified into three categories according to extent: 1) biopsy only, 2) limited (diagnostic) dissection, and 3) complete (therapeutic) dissection. The incidence of postirradiation lymphedema was found to be strongly dependent upon the extent of dissection. Patients undergoing limited (diagnostic) dissection followed by pelvic irradiation have a 25-30% risk of developing this debilitating complication. In patients undergoing complete (therapeutic) dissection followed by pelvic irradiation lymphedema has been observed in 66% of cases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pilepich</LastName><ForeName>M V</ForeName><Initials>MV</Initials></Author><Author ValidYN="Y"><LastName>Asbell</LastName><ForeName>S O</ForeName><Initials>SO</Initials></Author><Author ValidYN="Y"><LastName>Mulholland</LastName><ForeName>G S</ForeName><Initials>GS</Initials></Author><Author ValidYN="Y"><LastName>Pajak</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Prostate</MedlineTA><NlmUniqueID>8101368</NlmUniqueID><ISSNLinking>0270-4137</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002277" MajorTopicYN="N">Carcinoma</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011879" MajorTopicYN="N">Radiotherapy Dosage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1984</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1984</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1984</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">6483687</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006A04 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 006A04 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:6483687
|texte= Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:6483687" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |